CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-05 | Biller Scott Chief Scientific Officer | Sale | −701 | $76.76 | $54K | 53,459 |
| 2018-02-05 | Biller Scott Chief Scientific Officer | Sale | −400 | $78.03 | $31K | 53,059 |
| 2018-02-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock options (right to buy) | −64 | 1,803 | ||
| 2018-02-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock options (right to buy) | −2,936 | 31,154 | ||
| 2018-02-01 | Bowden Christopher Chief Medical Officer | Option exercise | +2,000 | $35.16 | $70K | 2,881 |
| 2018-02-01 | Bowden Christopher Chief Medical Officer | Sale | −1,315 | $78.50 | $103K | 1,566 |
| 2018-02-01 | Bowden Christopher Chief Medical Officer | Sale | −685 | $79.23 | $54K | 881 |
| 2018-02-01 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −2,000 | 107,000 | ||
| 2018-02-01 | Schenkein David P Chief Executive Officer | Option exercise | +13,000 | $0.30 | $4K | 13,000 |
| 2018-02-01 | Schenkein David P Chief Executive Officer | Sale | −8,540 | $78.50 | $670K | 4,460 |
| 2018-02-01 | Schenkein David P Chief Executive Officer | Sale | −4,460 | $79.23 | $353K | 0 |
| 2018-02-01 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −13,000 | 104,567 | ||
| 2018-01-26 | Schenkein David P Chief Executive Officer | Option exercise | +23,572 | $0.30 | $7K | 23,572 |
| 2018-01-26 | Schenkein David P Chief Executive Officer | Sale | −9,237 | $80.35 | $742K | 14,335 |
| 2018-01-26 | Schenkein David P Chief Executive Officer | Sale | −11,369 | $81.40 | $925K | 2,966 |
| 2018-01-26 | Schenkein David P Chief Executive Officer | Sale | −2,966 | $82.22 | $244K | 0 |
| 2018-01-26 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −23,572 | 117,567 | ||
| 2018-01-24 | Schenkein David P Chief Executive Officer | Option exercise | +20 | $0.30 | $6 | 20 |
| 2018-01-24 | Schenkein David P Chief Executive Officer | Sale | −20 | $80.01 | $2K | 0 |
| 2018-01-24 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −20 | 141,139 |
Page 67 of 80 · 1,590 trades